Pipeline: Overview

Allarity Therapeutics is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP® companion diagnostic to select and treat patients most likely to benefit from treatment. 
Allarity’s other clinical development activities

Allarity is also supporting development of a limited number of external programs.